Anthranilyl-Ala-Phe-Ala-Phe-Glu-Val-Phe-nitro-Tyr-Asp is a dual-labeled peptide containing an anthranilamide donor and nitrotyrosine acceptor for FRET-based protease assays. The sequence presents multiple hydrophobic and acidic residues shaping substrate specificity. Researchers monitor fluorescence changes to study cleavage patterns and enzyme selectivity. Applications include substrate engineering, detailed kinetic profiling, and protease-substrate mapping.
CAT No: R2551
CAS No:143147-75-5
Synonyms/Alias:Fluorescent Substrate for Glu-Specific Proteases;143147-75-5;GGFWDXWGSVJEBX-XMJIKGBQSA-N;HY-P3949;CS-0634383;Anthranilyl-Ala-Phe-Ala-Phe-Glu-Val-Phe-nitro-Tyr-Asp;ANTHRANILYL-ALA-PHE-ALA-PHE-GLU-VAL-PHE- NITRO-TYR-;630-812-6;
1. Cationic cell-penetrating peptides are potent furin inhibitors
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.